Navigation Links
Insmed to Host 2012 First Quarter Earnings Conference Call
Date:4/24/2012

timing of and costs associated with pre-clinical studies and clinical trials, the development of our products, and the business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  Our results may be affected by such factors as the receipt and timing of FDA and other regulatory reviews and approvals, if at all, competitive developments affecting our product development, delays in product development or clinical trials, and patent disputes involving currently developing products.  The risks and uncertainties include, without limitation, we may experience unexpected regulatory actions, delays or requests, our future clinical trials may not be successful, we may be unsuccessful in developing our product candidates or receiving necessary regulatory approvals, we may experience delays in our product development or clinical trials, our product candidates may not prove to be commercially successful, our expenses may be higher than anticipated and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2011. Investors are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release.  We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

Investor Relations Contact:
Brian Ritchie – FTI Consulting
212-850-5683
brian.ritchie@fticonsulting.com

Media Contact:
Irma Gomez-Dib – FTI Consulting
212-850-576
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call
2. Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference
3. Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication
4. Insmed Incorporated Provides Regulatory Update
5. Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
7. Insmeds ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
8. Insmed Announces First Quarter 2011 Financial Results
9. Insmed to Host 2011 First Quarter Earnings Conference Call
10. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
11. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
(Date:1/23/2015)... South Africa , Jan. 23, 2015   Leatt ... of personal protective equipment for all forms of sports, ... flagship Leatt-Brace® neck brace, announced today that the UISP ... federation, now requires all riders to wear a neck ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... May 26 Data from the CREST (Carotid ... in The New England Journal of Medicine. ... safety and longer-term outcomes for symptomatic and asymptomatic men ... heart attack were also similar for both therapies. Abbott,s ...
... Lead Candidate, LT-NS001, Shows Evidence of Improved GI Safety for Arthritis Patients ... WALTHAM, Mass. , May 26 ... closed on a $16.9 million Series C equity financing.  The round was ... and Novitas Capital. , , , ...
Cached Medicine Technology:The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery 2The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery 3The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery 4The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery 5The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery 6Logical Therapeutics Secures $16.9M Series C Financing Round 2
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... 1 edition of The Journal of Immunology provide key ... Ph.D., a principal investigator in SBRIs Viral Vaccines Program ... Southwestern Medical Center, is senior author on one of ... critical symptom of AIDS, is likely a part of ...
... 6 Hundreds of health information,technology experts ... produced by Inland Northwest Health Services, September ... health information,technology projects and initiatives on the ... Services (INHS) manages one of the nation,s,most ...
... 6 Following today,s startling survey by,the Centers ... in youth,suicide in more than 15 years, the ... raft of expert tips and resources to help,youngsters, ... the warning,signs, life-saving tips, and free resources to ...
... should be the first line of prevention against ... hypertension. While banding is similarly effective in reducing ... fatal complications and is more expensive. These findings ... Transplantation, a journal by John Wiley & Sons. ...
... B. Ajluni, D.O., American Osteopathic,Association (AOA) President, CHICAGO, ... health insurance to 47 million --- as announced in ... a disturbing trend signaling,more must be done to increase ... return this week from the summer recess, reauthorizing the,State ...
... Sept. 6 The National,Osteoporosis Foundation (NOF) has ... a 10-city tour starting September 8th and culminating ... across the,country to Start Right, Stay Strong for ... and fun that offers individuals information on bone,health, ...
Cached Medicine News:Health News:SIV infection of natural hosts provides new insights into HIV disease complexity 2Health News:Jump in Youth Suicide Prompts National Children's Charity KidsPeace to Issue Tips on Prevention, Warning Signs 2Health News:Jump in Youth Suicide Prompts National Children's Charity KidsPeace to Issue Tips on Prevention, Warning Signs 3Health News:Jump in Youth Suicide Prompts National Children's Charity KidsPeace to Issue Tips on Prevention, Warning Signs 4Health News:Preventing variceal bleeding 2Health News:Preventing variceal bleeding 3Health News:National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour 2
The KAVD Venous Cannula is the first of its kind. It is a combination of cannulae/venous line designed to "bridge the gap between the patient and the Medtronic Resting Heart System circuit....
... Pediatric Arterial Cannula is second ... of pediatric arterial cannulae. It ... models such as a kink-resistant, ... Flow-Guard™ introducer technology for easy ...
The Select 3D Arterial cannulae from Medtronic features a tip configuration which diffuses the flow through multiple outlets. This unique tip design provides reduced velocity with one central and thr...
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant....
Medicine Products: